{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "marketState": "PRE", "messageBoardId": "finmb_647650276", "regularMarketChangePercent": 4.7619, "regularMarketPrice": 3.08, "exchange": "NCM", "shortName": "CytoMed Therapeutics Limited", "longName": "CytoMed Therapeutics Limited", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "firstTradeDateMilliseconds": 1681479000000, "priceHint": 4, "regularMarketChange": 0.13999987, "regularMarketTime": 1684180805, "regularMarketDayHigh": 3.491, "regularMarketDayRange": "2.8447 - 3.491", "regularMarketDayLow": 2.8447, "regularMarketVolume": 256433, "regularMarketPreviousClose": 2.94, "bid": 0.0, "ask": 0.0, "bidSize": 29, "askSize": 10, "fullExchangeName": "NasdaqCM", "financialCurrency": "SGD", "regularMarketOpen": 2.93, "averageDailyVolume3Month": 302568, "averageDailyVolume10Day": 302010, "fiftyTwoWeekLowChange": 0.72, "fiftyTwoWeekLowChangePercent": 0.30508476, "fiftyTwoWeekRange": "2.36 - 4.8", "fiftyTwoWeekHighChange": -1.7200003, "fiftyTwoWeekHighChangePercent": -0.35833338, "fiftyTwoWeekLow": 2.36, "fiftyTwoWeekHigh": 4.8, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.21, "sharesOutstanding": 10939800, "bookValue": 0.196, "fiftyDayAverage": 3.4667273, "fiftyDayAverageChange": -0.38672733, "fiftyDayAverageChangePercent": -0.11155401, "twoHundredDayAverage": 3.4667273, "twoHundredDayAverageChange": -0.38672733, "twoHundredDayAverageChangePercent": -0.11155401, "marketCap": 34491688, "priceToBook": 15.714286, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2023-04-14", "tradeable": false, "cryptoTradeable": false, "displayName": "CytoMed Therapeutics", "symbol": "GDTC"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "1 Commonwealth Lane, No. 08-22", "city": "Singapore", "zip": "149544", "country": "Singapore", "phone": "65 6250 7738", "website": "https://w2.cytomed.sg", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers. The company's lead product candidate is CTM-N2D, which consists of expanded gamma delta T cells grafted with natural killer group 2D ligands-targeting chimeric antigen receptor to improve anti-cancer cytotoxicity. It is also developing iPSC-gdNKT, which utilizes iPSC as a starting material to generate gdNKT, a synthetic hybrid of a gamma delta T cell and a NK cell; and CTM-GDT, a product candidate that consists of expanded gamma delta T cells, and exploits the multiple recognition system of gamma delta T cell to recognize and treat a range of cancers. The company has a research collaboration agreement with The University of Texas MD Anderson Cancer Center to use gamma-delta T cells for the treatment of acute myeloid leukemia and breast cancer. The company was incorporated in 2018 and is headquartered in Singapore.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Chee Kong  Choo", "age": 64, "title": "Exec. Chairman", "yearBorn": 1958, "fiscalYear": 2022, "totalPay": {"raw": 5454, "fmt": "5.45k", "longFmt": "5,454"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Wee Kiat  Tan Ph.D.", "age": 35, "title": "COO & Director", "yearBorn": 1987, "fiscalYear": 2022, "totalPay": {"raw": 67442, "fmt": "67.44k", "longFmt": "67,442"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Jieming  Zeng", "age": 49, "title": "Chief Scientific & Medical Officer and Director", "yearBorn": 1973, "fiscalYear": 2022, "totalPay": {"raw": 78481, "fmt": "78.48k", "longFmt": "78,481"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Tien Wee  Luk", "age": 36, "title": "Chief Clinical Officer & Director", "yearBorn": 1986, "fiscalYear": 2022, "totalPay": {"raw": 0, "fmt": null, "longFmt": "0"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Yvonne  Goh", "age": 32, "title": "Chief Financial Officer", "yearBorn": 1990, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Yoong Ying  Tan", "age": 33, "title": "Chief Corp. Officer", "yearBorn": 1989, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}